Extracorporeal CO2 Removal Devices Market Snapshot (2022 to 2032)

Newly-released Extracorporeal CO2 Removal Devices Market industry analysis report by Future Market Insights shows that global sales of the Extracorporeal CO2 Removal Devices Market in 2021 were held at US$ 91.6 million. With a CAGR of 5.8% from 2022 to 2032, the market is projected to reach a valuation of US$ 170.9 million by 2032. Extracorporeal CO2 Machines is expected to be the highest revenue-generating category, projected to grow at a CAGR of 6.2% from 2022 to 2032.

Attribute Details
Global Extracorporeal CO2 Removal Devices Market (2022) US$ 97 million
Global Extracorporeal CO2 Removal Devices Market (2032) US$ 170.9 million
Global Extracorporeal CO2 Removal Devices Market CAGR (2022 to 2032) 5.8%
The USA Extracorporeal CO2 Removal Devices Market CAGR (2022 to 2032) 6.1%
Key Companies Profiled
  • Medtronic
  • Getinge AB
  • Xenios AG
  • Alung Technologies
  • ESTOR S.P.A
  • Medica Spa
  • Aferectica Srl

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Extracorporeal CO2 Removal Devices Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Extracorporeal CO2 Removal Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value increased at around 5.6% CAGR, wherein, countries such as Germany, the USA, China, and Japan held a significant share in the global market.

The growing usage of advanced analytics in pharma and medical testing are the key factors influencing the adoption of Extracorporeal CO2 Removal Devices. Owing to this, the market is projected to grow at a CAGR of 5.8% over the coming 10 years.

Health systems and Extracorporeal CO2 Removal Devices enterprises to improve treatment, monetary, and sustainability frameworks while minimizing the costs of healthcare are rapidly adopting analytical solutions. Healthcare financing organizations and government bodies are implementing analytics through claim management and fraud prevention, which is fueling market growth.

The growing elderly population and their increased proclivity for various acute and chronic diseases are likely to drive the expansion of the worldwide extracorporeal carbon dioxide removal market. Furthermore, rising incidences of pulmonary obstructive illness are predicted to aid in the global market's expansion. On the contrary, the risk of infection, hypoxemia, or thrombosis produced by the restricted flow of blood via the circuit may result in severe health issues, posing a long-term challenge to market expansion.

What Clinical Potential benefits of ECCO2R Devices are Expected to Drive Global Market Growth?

According to the World Health Organization (WHO), around 251 million people worldwide suffer from a chronic pulmonary obstructive condition. The World Health Organization expected that the number of instances of pulmonary obstructive disease would rise due to an increase in smoking among the population, which would raise the global extracorporeal carbon dioxide removal (ECCO2R) device market sales in the coming years.

Furthermore, clinical benefits provided by ECCO2R removal devices, including effective gas exchange, vitalizing blood flow, and strong lung support, are expected to drive the worldwide ECCO2R devices market revenue during the forecast period.

Extracorporeal CO2 removal devices are efficient, safe, and cost-effective. These technologies have been proposed for use in ventilation assistance in clinical settings where they may be effective, such as COPD exacerbation and acute respiratory distress syndrome (ARDS). The rising prevalence of COPD around the world is expected to fuel market expansion.

Extracorporeal CO2 removal devices are an effective therapy for individuals with hypercapnia respiratory failure and may assist clinicians and healthcare partners to improve lung-protective ventilation. These devices can remove enough CO2 to allow for a 50% reduction in alveolar minute ventilation, resulting in a significant reduction in PaCO2. As a result, the multiple benefits connected with these devices are likely to boost the overall market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Regional Analysis

Which Region is projected to offer the Largest Opportunity for the Extracorporeal CO2 Removal Devices Market?

North America is likely to continue to dominate the global extracorporeal CO2 removal market throughout the analysis period, owing to the early adoption of innovations and a large patient pool of COPD and ARDS patients. The increased popularity of novel clinical innovations is attributable to the expansion of the regional market. The spread of chronic respiratory illnesses and the flood of demand for quick and safe minimally intrusive ventilation procedures have accelerated the development of the extracorporeal CO2 removal industry in North America.

Country-wise Analysis

The USA Market Analysis

The United States has been a pioneer in the Extracorporeal CO2 Removal Devices Market. In recent years, the utilization of Extracorporeal CO2 Removal Devices in the USA expanded due to a growing emphasis on the removal of carbon dioxide in the healthcare sector. The increase in the number of specialized clinics in the United States has also provided new opportunities for market participants.

United Kingdom Market Analysis

The market in the United Kingdom is expected to reach a valuation of US$ 62 million by 2032. Growing at a CAGR of 6.1% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 27.5 million.

Japan Market Analysis

In Japan, the market is projected to garner an absolute dollar opportunity of US$ 3.3 million with a CAGR of 7.1% during the forecast period. The market in the country is expected to reach a valuation of US$ 6.7 million by 2032.

South Korea Market Analysis

The market in South Korea is expected to reach a valuation of US$ 4.5 million, growing at a CAGR of 5.7% from 2022 to 2032. The market in the country is expected to witness an absolute dollar opportunity of US$ 1.9 million during the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why Extracorporeal CO2 Machines Account for Highest Share in the Market?

Extracorporeal CO2 machines accounted for over half of the total extracorporeal CO2 removal devices demand. The market for Extracorporeal CO2 Machines is expected to grow at a CAGR of 6.2%. Advancements in technical simplification have allowed the usage of additional corporeal CO2 removal equipment to accelerate dramatically, reducing some of the primary difficulties connected to ECMO. Extracorporeal carbon dioxide removal equipment is theoretically simpler and has comparatively fewer staff needs along with logistical requirements,[mg] as patients may prefer them over ECMO.

Competitive Analysis

The leading players in the extracorporeal CO2 removal system market have used various methods to boost growth potential in the coming years. Collaborations, alliances, mergers, product approvals, and novel product launches are some of the primary methods used by leading companies to create growth avenues in the market.

Some of the key players operating in the market include Medtronic, Getinge AB, Xenios AG, ALung Technologies, ESTOR S.P.A., Medica Spa, and Aferectica Srl.

Some of the recent developments in the key Extracorporeal CO2 Removal Devices Market are as follows:

  • In December 2018, ALung Technologies made considerable progress in clinical trial programs for the Hemolung Respiratory Assist System (RAS), a catheter that plays an important part in the extracorporeal Co2 removal process.
  • In September 2017, Hemolung Respiratory Assist Device (RAS) received IDE (Investigational Device Exemption) approval to conduct VENT-AVOID trials of the system.

Similarly, recent developments related to companies offering Extracorporeal CO2 Removal Devices Market have been tracked by the team at Future Market Insights, which are available in the full report.

Market Segments Covered in Extracorporeal CO2 Removal Devices Market Analysis

By Product Type:

  • Extracorporeal CO2 Machines
  • Disposables
  • Other Product Types

By Application Type:

  • Acute Respiratory Distress Syndrome (ARDS)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bridge to Lung Transplant
  • Other Applications

By Sample Type:

  • Venovenous
  • Arteriovenous

By Region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is the current worth of the Extracorporeal CO2 Removal Devices Market?

The global market is worth more than US$ 91.6 million at present.

What is the global Extracorporeal CO2 Removal Devices Markets market growth?

The market is expected to witness a CAGR of 5.8% from 2022 to 2032.

Which Region accounted for the largest Extracorporeal CO2 Removal Devices Market?

North America dominated the Extracorporeal CO2 Removal Devices Market. This is attributable to increased spending on procedures and the easy availability of the products.

What is driving revenue for Extracorporeal CO2 Removal Devices Market?

The market revenue is being driven primarily by the growing healthcare industry, which has consequently accelerated manufacturing

Which are the top 5 countries driving demand for Extracorporeal CO2 Removal Devices Market?

The top 5 countries driving demand for Extracorporeal CO2 Removal Devices Market are the USA, China, Japan, India, the United Kingdom, and South Korea.

Who are the leading industry participants in the global Extracorporeal CO2 Removal Devices Market?

Alung Technologies, Inc., Xenios AG, ESTOR S.P.A, Medtronic Plc., Medica S.P.A., and Getinge Group are among the key players operating in the market.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Summary of Statistics
    1.3. Key Market Characteristics & Attributes
    1.4. Future Market Insights Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
    3.1. Risk Assessment
        3.1.1. COVID-19 Crisis and Impact on Extracorporeal CO2 Removal Devices
        3.1.2. COVID-19 Impact Benchmark with Previous Crisis
        3.1.3. Impact on Market Value (US$ million)
        3.1.4. Assessment by Key Countries
        3.1.5. Assessment by Key Market Segments
        3.1.6. Action Points and Recommendation for Suppliers
    3.2. Key Trends Impacting the Market
    3.3. Formulation and Product Development Trends
4. Market Background
    4.1. Market, by Key Countries
    4.2. Market Opportunity Assessment (US$ million)
        4.2.1. Total Available Market
        4.2.2. Serviceable Addressable Market
        4.2.3. Serviceable Obtainable Market
    4.3. Market Scenario Forecast
        4.3.1. Demand in optimistic Scenario
        4.3.2. Demand in Likely Scenario
        4.3.3. Demand in Conservative Scenario
    4.4. Investment Feasibility Analysis
        4.4.1. Investment in Established Markets
            4.4.1.1. In Short Term
            4.4.1.2. In Long Term
        4.4.2. Investment in Emerging Markets
            4.4.2.1. In Short Term
            4.4.2.2. In Long Term
    4.5. Forecast Factors - Relevance & Impact
        4.5.1. Top Companies Historical Growth
        4.5.2. Growth in Automation, By Country
        4.5.3. Patch Management Adoption Rate, By Country
    4.6. Market Dynamics
        4.6.1. Market Driving Factors and Impact Assessment
        4.6.2. Prominent Market Challenges and Impact Assessment
        4.6.3. Patch Management Market Opportunities
        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
    5.2. Banking on with Segments High Incremental Opportunity
    5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
    6.1. Historical Market Analysis, 2015 to 2021
    6.2. Current and Future Market Projections, 2022 to 2032
    6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
    7.1. Historical Market Value (US$ million) Analysis, 2015 to 2021
    7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
        7.2.1. Y-o-Y Growth Trend Analysis
        7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product type
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ million) Analysis By Product type, 2015 to 2021
    8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Product type, 2022 to 2032
        8.3.1. Extracorporeal CO2 Machines
        8.3.2. Disposables
        8.3.3. Other Product Types
    8.4. Market Attractiveness Analysis By Product type
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ million) Analysis By Application, 2015 to 2021
    9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032
        9.3.1. Acute Respiratory Distress Syndrome (ARDS)
        9.3.2. Chronic Obstructive Pulmonary Disease (COPD)
        9.3.3. Bridge to Lung Transplant
        9.3.4. Other Applications
    9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Sample type
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ million) Analysis By Application, 2015 to 2021
    10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032
        10.3.1. Venovenous
        10.3.2. Arteriovenous
    10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
    11.1. Introduction
    11.2. Historical Market Size (US$ million) Analysis By Region, 2015 to 2021
    11.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. Asia Pacific
        11.3.5. Middle East and Africa (MEA)
    11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    12.1. Introduction
    12.2. Pricing Analysis
    12.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
    12.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
        12.4.1. By Country
            12.4.1.1. The USA
            12.4.1.2. Canada
            12.4.1.3. Rest of North America
        12.4.2. By Product type
        12.4.3. By Application
        12.4.4. By Sample type
    12.5. Market Attractiveness Analysis
        12.5.1. By Country
        12.5.2. By Product type
        12.5.3. By Application
        12.5.4. By Sample type
13. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    13.1. Introduction
    13.2. Pricing Analysis
    13.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
    13.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
        13.4.1. By Country
            13.4.1.1. Brazil
            13.4.1.2. Mexico
            13.4.1.3. Rest of Latin America
        13.4.2. By Product type
        13.4.3. By Application
        13.4.4. By Sample type
    13.5. Market Attractiveness Analysis
        13.5.1. By Country
        13.5.2. By Product type
        13.5.3. By Application
        13.5.4. By Sample type
14. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    14.1. Introduction
    14.2. Pricing Analysis
    14.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
    14.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
        14.4.1. By Country
            14.4.1.1. Germany
            14.4.1.2. France
            14.4.1.3. The United Kingdom
            14.4.1.4. Italy
            14.4.1.5. Benelux
            14.4.1.6. Nordic Countries
            14.4.1.7. Rest of Europe
        14.4.2. By Product type
        14.4.3. By Application
        14.4.4. By Sample type
    14.5. Market Attractiveness Analysis
        14.5.1. By Country
        14.5.2. By Product type
        14.5.3. By Application
        14.5.4. By Sample type
15. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    15.1. Introduction
    15.2. Pricing Analysis
    15.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
    15.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
        15.4.1. By Country
            15.4.1.1. China
            15.4.1.2. Japan
            15.4.1.3. South Korea
            15.4.1.4. Rest of Asia Pacific
        15.4.2. By Product type
        15.4.3. By Application
        15.4.4. By By Sample type
    15.5. Market Attractiveness Analysis
        15.5.1. By Country
        15.5.2. By Product type
        15.5.3. By Application
        15.5.4. By Sample type
16. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    16.1. Introduction
    16.2. Pricing Analysis
    16.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
    16.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
        16.4.1. By Country
            16.4.1.1. GCC Countries
            16.4.1.2. South Africa
            16.4.1.3. Turkey
            16.4.1.4. Rest of Middle East and Africa
        16.4.2. By Product type
        16.4.3. By Application
        16.4.4. By Sample type
    16.5. Market Attractiveness Analysis
        16.5.1. By Country
        16.5.2. By Product type
        16.5.3. By Application
        16.5.4. By Sample type
17. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
    17.1. Introduction
        17.1.1. Market Value Proportion Analysis, By Key Countries
        17.1.2. Global Vs. Country Growth Comparison
    17.2. US Market Analysis
        17.2.1. Value Proportion Analysis by Market Taxonomy
        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.2.2.1. By Product type
            17.2.2.2. By Application
            17.2.2.3. By Sample type
    17.3. Canada Market Analysis
        17.3.1. Value Proportion Analysis by Market Taxonomy
        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.3.2.1. By Product type
            17.3.2.2. By Application
            17.3.2.3. By Sample type
    17.4. Mexico Market Analysis
        17.4.1. Value Proportion Analysis by Market Taxonomy
        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.4.2.1. By Product type
            17.4.2.2. By Application
            17.4.2.3. By Sample type
    17.5. Brazil Market Analysis
        17.5.1. Value Proportion Analysis by Market Taxonomy
        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.5.2.1. By Product type
            17.5.2.2. By Application
            17.5.2.3. By Sample type
    17.6. Germany Market Analysis
        17.6.1. Value Proportion Analysis by Market Taxonomy
        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.6.2.1. By Product type
            17.6.2.2. By Application
            17.6.2.3. By Sample type
    17.7. France Market Analysis
        17.7.1. Value Proportion Analysis by Market Taxonomy
        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.7.2.1. By Product type
            17.7.2.2. By Application
            17.7.2.3. By Sample type
    17.8. Italy Market Analysis
        17.8.1. Value Proportion Analysis by Market Taxonomy
        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.8.2.1. By Product type
            17.8.2.2. By Application
            17.8.2.3. By Sample type
    17.9. BENELUX Market Analysis
        17.9.1. Value Proportion Analysis by Market Taxonomy
        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.9.2.1. By Product type
            17.9.2.2. By Application
            17.9.2.3. By Sample type
    17.10. The United Kingdom Market Analysis
        17.10.1. Value Proportion Analysis by Market Taxonomy
        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.10.2.1. By Product type
            17.10.2.2. By Application
            17.10.2.3. By Sample type
    17.11. Nordic Countries Market Analysis
        17.11.1. Value Proportion Analysis by Market Taxonomy
        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.11.2.1. By Product type
            17.11.2.2. By Application
            17.11.2.3. By Sample type
    17.12. China Market Analysis
        17.12.1. Value Proportion Analysis by Market Taxonomy
        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.12.2.1. By Product type
            17.12.2.2. By Application
            17.12.2.3. By Sample type
    17.13. Japan Market Analysis
        17.13.1. Value Proportion Analysis by Market Taxonomy
        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.13.2.1. By Product type
            17.13.2.2. By Application
            17.13.2.3. By Sample type
    17.14. South Korea Market Analysis
        17.14.1. Value Proportion Analysis by Market Taxonomy
        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.14.2.1. By Product type
            17.14.2.2. By Application
            17.14.2.3. By Sample type
    17.15. GCC Countries Market Analysis
        17.15.1. Value Proportion Analysis by Market Taxonomy
        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.15.2.1. By Product type
            17.15.2.2. By Application
            17.15.2.3. By Sample type
    17.16. South Africa Market Analysis
        17.16.1. Value Proportion Analysis by Market Taxonomy
        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.16.2.1. By Product type
            17.16.2.2. By Application
            17.16.2.3. By Sample type
    17.17. Turkey Market Analysis
        17.17.1. Value Proportion Analysis by Market Taxonomy
        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
            17.17.2.1. By Product type
            17.17.2.2. By Application
            17.17.2.3. By Application
        17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
    18.1. Market Analysis by Tier of Companies
    18.2. Market Concentration
    18.3. Market Share Analysis of Top Players
    18.4. Market Presence Analysis
        18.4.1. By Regional footprint of Players
        18.4.2. Product footprint by Players
19. Competition Analysis
    19.1. Competition Dashboard
    19.2. Competition Benchmarking
    19.3. Competition Deep Dive
        19.3.1. IBM
            19.3.1.1. Overview
            19.3.1.2. Product Portfolio
            19.3.1.3. Sales Footprint
            19.3.1.4. Strategy Overview
        19.3.2. SYMANTEC
            19.3.2.1. Overview
            19.3.2.2. Product Portfolio
            19.3.2.3. Sales Footprint
            19.3.2.4. Strategy Overview
        19.3.3. MICRO FOCUS
            19.3.3.1. Overview
            19.3.3.2. Product Portfolio
            19.3.3.3. Sales Footprint
            19.3.3.4. Strategy Overview
        19.3.4. QUALYS
            19.3.4.1. Overview
            19.3.4.2. Product Portfolio
            19.3.4.3. Sales Footprint
            19.3.4.4. Strategy Overview
        19.3.5. SOLARWINDS
            19.3.5.1. Overview
            19.3.5.2. Product Portfolio
            19.3.5.3. Sales Footprint
            19.3.5.4. Strategy Overview
        19.3.6. IVANTI
            19.3.6.1. Overview
            19.3.6.2. Product Portfolio
            19.3.6.3. Sales Footprint
            19.3.6.4. Strategy Overview
        19.3.7. MANAGEENGINE
            19.3.7.1. Overview
            19.3.7.2. Product Portfolio
            19.3.7.3. Sales Footprint
            19.3.7.4. Strategy Overview
        19.3.8. CONNECTWISE
            19.3.8.1. Overview
            19.3.8.2. Product Portfolio
            19.3.8.3. Sales Footprint
            19.3.8.4. Strategy Overview
        19.3.9. AVAST
            19.3.9.1. Overview
            19.3.9.2. Product Portfolio
            19.3.9.3. Sales Footprint
            19.3.9.4. Strategy Overview
        19.3.10. AUTOMOX
            19.3.10.1. Overview
            19.3.10.2. Product Portfolio
            19.3.10.3. Sales Footprint
            19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Recommendations

Healthcare

Extracorporeal Membrane Oxygenation Machine Market

September 2024

REP-GB-14300

320 pages

Healthcare

Tattoo Removal Laser Market

March 2024

REP-GB-2013

342 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Extracorporeal CO2 Removal Devices Market

Schedule a Call